Journal Article Summary
The article focuses on the structural analysis of a compound known as Desvenlafaxinium chloranilate ethyl acetate solvate. Understanding the structure of this compound is significant because it relates to Desvenlafaxine, a medication used to treat depression and anxiety disorders. By studying its crystal structure, researchers aim to gain insights into how the compound behaves at a molecular level, which can inform its pharmacological properties and potential therapeutic effects.
The researchers employed crystallography techniques to analyze the compound's structure, revealing details about its molecular arrangement. They found that the compound consists of a cation and an anion, with specific geometric configurations, including a slightly distorted chair conformation of the cyclohexyl ring. The study also noted the presence of hydrogen bonds that contribute to the stability of the crystal structure, indicating how the molecules interact with each other in solid form.
While the study provides valuable information about the compound's structure, it has limitations, such as the specific conditions under which the crystal was analyzed, which may not represent all possible states of the compound. Patients should be aware that while structural studies can enhance understanding of medications, they do not directly translate to clinical outcomes. It is advisable for readers to discuss any concerns or questions about medications like Desvenlafaxine with their healthcare providers to ensure safe and effective use.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Kaur Manpreet, Jasinski Jerry P., Butcher Ray J., Yathirajan H. S., Byrappa K.. Desvenlafaxinium chloranilate ethyl acetate solvate. Acta Crystallographica Section E: Structure Reports Online 2013. DOI: 10.1107/S1600536813025312. PMID: 24098238. PMCID: PMC3790419.
Featured Pill Pals Product
Desvenlafaxine Succinate Extended Release 50 mg Tablets --- 30 Count --- Generic for Pristiq --- Slate Run Pharma
Desvenlafaxine Succinate Extended Release 50 mg Tablets — 30 Count — Generic for Pristiq — Slate Run Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
